Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064, United States.
Department of Peptide Therapeutics, Genentech, South San Francisco, California 94080, United States.
J Am Chem Soc. 2024 Feb 21;146(7):4582-4591. doi: 10.1021/jacs.3c10949. Epub 2024 Feb 8.
The effort to modulate challenging protein targets has stimulated interest in ligands that are larger and more complex than typical small-molecule drugs. While combinatorial techniques such as mRNA display routinely produce high-affinity macrocyclic peptides against classically undruggable targets, poor membrane permeability has limited their use toward primarily extracellular targets. Understanding the passive membrane permeability of macrocyclic peptides would, in principle, improve our ability to design libraries whose leads can be more readily optimized against intracellular targets. Here, we investigate the permeabilities of over 200 macrocyclic 10-mers using the thioether cyclization motif commonly found in mRNA display macrocycle libraries. We identified the optimal lipophilicity range for achieving permeability in thioether-cyclized 10-mer cyclic peptide-peptoid hybrid scaffolds and showed that permeability could be maintained upon extensive permutation in the backbone. In one case, changing a single amino acid from d-Pro to d-NMe-Ala, representing the loss of a single methylene group in the side chain, resulted in a highly permeable scaffold in which the low-dielectric conformation shifted from the canonical cross-beta geometry of the parent compounds into a novel saddle-shaped fold in which all four backbone NH groups were sequestered from the solvent. This work provides an example by which pre-existing physicochemical knowledge of a scaffold can benefit the design of macrocyclic peptide mRNA display libraries, pointing toward an approach for biasing libraries toward permeability by design. Moreover, the compounds described herein are a further demonstration that geometrically diverse, highly permeable scaffolds exist well beyond conventional drug-like chemical space.
调节具有挑战性的蛋白质靶标这一努力激发了人们对更大、更复杂的配体的兴趣,这些配体比典型的小分子药物更复杂。虽然组合技术(如 mRNA 展示)通常可以针对经典上不可成药的靶标产生高亲和力的大环肽,但较差的膜通透性限制了它们在主要为细胞外靶标上的应用。原则上,了解大环肽的被动膜通透性将提高我们设计文库的能力,使文库的先导化合物更易于针对细胞内靶标进行优化。在这里,我们使用在 mRNA 展示大环库中常见的硫醚环化基序,研究了 200 多个大环 10 聚体的通透性。我们确定了实现硫醚环化 10 聚体环肽-肽段杂合体支架通透性的最佳亲脂性范围,并表明在骨架上进行广泛的置换仍可以保持通透性。在一种情况下,将单个氨基酸从 d-Pro 变为 d-NMe-Ala,代表侧链中失去一个亚甲基,这导致一个高度通透的支架,其中低介电构象从母体化合物的典型交叉-β几何形状转变为一种新颖的鞍形折叠,其中所有四个骨架 NH 基团都与溶剂隔离。这项工作提供了一个示例,通过该示例,支架的现有物理化学知识可以有益于大环肽 mRNA 展示文库的设计,指出了通过设计使文库偏向通透性的方法。此外,本文所描述的化合物进一步证明了具有不同几何形状的高度通透的支架存在于远超出传统药物化学空间的范围。